JP2023524990A5 - - Google Patents
Info
- Publication number
- JP2023524990A5 JP2023524990A5 JP2022567321A JP2022567321A JP2023524990A5 JP 2023524990 A5 JP2023524990 A5 JP 2023524990A5 JP 2022567321 A JP2022567321 A JP 2022567321A JP 2022567321 A JP2022567321 A JP 2022567321A JP 2023524990 A5 JP2023524990 A5 JP 2023524990A5
- Authority
- JP
- Japan
- Prior art keywords
- ndv
- protein
- transgene
- recombinant
- chimeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063021677P | 2020-05-07 | 2020-05-07 | |
| US63/021,677 | 2020-05-07 | ||
| US202063051858P | 2020-07-14 | 2020-07-14 | |
| US63/051,858 | 2020-07-14 | ||
| US202063057267P | 2020-07-27 | 2020-07-27 | |
| US63/057,267 | 2020-07-27 | ||
| US202063058435P | 2020-07-29 | 2020-07-29 | |
| US63/058,435 | 2020-07-29 | ||
| US202063059924P | 2020-07-31 | 2020-07-31 | |
| US63/059,924 | 2020-07-31 | ||
| PCT/US2021/022848 WO2021194826A2 (en) | 2020-03-24 | 2021-03-17 | Recombinant sars-cov-2 spike protein and uses thereof |
| USPCT/US2021/022848 | 2021-03-17 | ||
| PCT/US2021/031110 WO2021226348A2 (en) | 2020-05-07 | 2021-05-06 | Recombinant newcastle disease virus expressing sars-cov-2 spike protein and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524990A JP2023524990A (ja) | 2023-06-14 |
| JP2023524990A5 true JP2023524990A5 (https=) | 2024-05-29 |
Family
ID=78468787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567321A Pending JP2023524990A (ja) | 2020-05-07 | 2021-05-06 | ＳＡＲＳ－ＣｏＶ－２スパイクタンパク質を発現する組換えニューカッスル病ウイルス及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230310583A1 (https=) |
| EP (1) | EP4146674A4 (https=) |
| JP (1) | JP2023524990A (https=) |
| BR (1) | BR112022022604A2 (https=) |
| CA (1) | CA3178875A1 (https=) |
| MX (1) | MX2022013934A (https=) |
| WO (1) | WO2021226348A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021229270A1 (es) | 2020-05-13 | 2021-11-18 | Laboratorio Avi-Mex, S.A. De C.V. | Vacuna recombinante contra covid-19 en vector viral |
| CN113881704B (zh) * | 2021-11-17 | 2024-02-13 | 浙江迪福润丝生物科技有限公司 | 一种包含新型冠状病毒双抗原靶标序列组合的重组新城疫病毒载体及相应疫苗株和疫苗 |
| CN114196701B (zh) * | 2021-11-17 | 2023-10-10 | 浙江迪福润丝生物科技有限公司 | 一种sars-cov-2的二价重组新城疫病毒载体及相应疫苗株和制备方法 |
| CN114213547A (zh) * | 2021-12-16 | 2022-03-22 | 浙江迪福润丝生物科技有限公司 | 一种展示新冠s蛋白的融合蛋白和重组病毒粒子及其应用 |
| KR20240137110A (ko) * | 2022-02-02 | 2024-09-19 | 워싱턴 유니버시티 | 오미크론 코로나바이러스 백신 구조체 및 이를 제조하고 사용하는 방법 |
| CA3245533A1 (en) * | 2022-03-10 | 2023-09-14 | Icahn School Of Medicine At Mount Sinai | RECOMMENDED NEWCASTLE DISEASE VIRUS AND IMMUNOGENEOUS COMPOSITIONS INTENDED FOR USE IN THE PREVENTION OF COVID-19 |
| US20250228929A1 (en) * | 2022-04-03 | 2025-07-17 | Icahn School Of Medicine At Mount Sinai | Recombinant newcastle disease viruses and immunogenic compositions for use in immunizing against sars-cov-2 omicron variant |
| WO2024174012A1 (pt) * | 2023-02-24 | 2024-08-29 | Instituto Butantan | Composição imunogênica, uso da mesma e processo de obtenção de uma composição imunogênica combinada contra covid-19 e influenza sazonal |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2251034T3 (pl) * | 2005-12-02 | 2018-07-31 | Icahn School Of Medicine At Mount Sinai | Chimeryczne wirusy prezentujące nienatywne białka powierzchniowe i zastosowania tych wirusów |
| KR20260047644A (ko) * | 2017-03-30 | 2026-04-08 | 더 유니버서티 어브 퀸슬랜드 | 키메라 분자 및 그의 용도 |
| US20190382450A1 (en) * | 2018-06-18 | 2019-12-19 | University Of Maryland, College Park | Newcastle disease virus-based vectored vaccine |
-
2021
- 2021-05-06 MX MX2022013934A patent/MX2022013934A/es unknown
- 2021-05-06 BR BR112022022604A patent/BR112022022604A2/pt unknown
- 2021-05-06 CA CA3178875A patent/CA3178875A1/en active Pending
- 2021-05-06 EP EP21800838.1A patent/EP4146674A4/en active Pending
- 2021-05-06 US US17/922,777 patent/US20230310583A1/en active Pending
- 2021-05-06 JP JP2022567321A patent/JP2023524990A/ja active Pending
- 2021-05-06 WO PCT/US2021/031110 patent/WO2021226348A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524990A5 (https=) | ||
| Yao et al. | Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces | |
| US20210246431A1 (en) | Human Betacoronavirus Lineage C and Identification of N-Terminal Dipeptidyl Peptidase As Its Virus Receptor | |
| CN111603557A (zh) | 一种包膜替换型病毒载体疫苗及其构建方法 | |
| CN111560354A (zh) | 重组新型冠状病毒及其制备方法和应用 | |
| CN104962581B (zh) | 一种表达非洲猪瘟病毒p72蛋白的重组病毒疫苗株 | |
| CN109182380B (zh) | 杆状病毒表达的猪瘟e2亚单位疫苗的制备方法及应用 | |
| US20250228929A1 (en) | Recombinant newcastle disease viruses and immunogenic compositions for use in immunizing against sars-cov-2 omicron variant | |
| Yunus et al. | Elevated temperature triggers human respiratory syncytial virus F protein six-helix bundle formation | |
| CN107190013A (zh) | 一种以人Ad5复制缺陷型腺病毒为载体的寨卡病毒病疫苗 | |
| Bai et al. | Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses | |
| Tsurudome et al. | Identification of regions on the fusion protein of human parainfluenza virus type 2 which are required for haemagglutinin-neuraminidase proteins to promote cell fusion | |
| CN113817753A (zh) | 表达SARS-CoV-2纤突蛋白或其变异体SΔ21的假型化VSV病毒构建和应用 | |
| CN111154778B (zh) | 禽新城疫病毒新型基因工程亚单位疫苗 | |
| Escoffier et al. | Infection of chicken embryonic fibroblasts by measles virus: adaptation at the virus entry level | |
| US20070270361A1 (en) | Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof | |
| JP3809502B2 (ja) | ハンタウィルス抗原蛋白質およびモノクローナル抗体 | |
| CN114213547A (zh) | 一种展示新冠s蛋白的融合蛋白和重组病毒粒子及其应用 | |
| KR20060123291A (ko) | 신규한 비정형 폐렴-원인성 바이러스 | |
| CN114315986A (zh) | 新型冠状病毒mRNA疫苗及其制备方法与应用 | |
| CN119431524A (zh) | Rsv融合前构象f蛋白的突变体及其应用 | |
| US20030166168A1 (en) | Variant varicella-zoster viruses and methods of use | |
| CN102558342B (zh) | 猪4-1bb受体，编码其的基因及其应用 | |
| RU2813150C2 (ru) | Выделенный рекомбинантный вирус на основе вируса гриппа для индукции специфического иммунитета к вирусу гриппа и/или профилактики заболеваний, вызванных вирусом гриппа | |
| Tsunekun et al. | Increase in the neuraminidase activity of a nonpathogenic Newcastle disease virus isolate during passaging in chickens |